1.56
price down icon6.59%   -0.11
after-market Handel nachbörslich: 1.50 -0.06 -3.85%
loading

Finanzdaten der Vigil Neuroscience Inc-Aktie (VIGL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
10.24%
21.41
23.86 22.32 21.91 20.77
Depreciation and Amortization
0.00%
0.113
0.113 0.11 0.111 0.065
Operating Income/Loss
10.24%
-21.41
-23.86 -22.32 -21.91 -20.77
Nonoperating Income/Loss
12.36%
1.475
1.683 1.826 1.739 0.98
Income/Loss From Continuing Operations Before Tax
10.07%
-19.94
-22.17 -20.50 -20.17 -19.80
Income/Loss From Continuing Operations After Tax
10.07%
-19.94
-22.17 -20.50 -20.17 -19.80
Net Income/Loss
10.07%
-19.94
-22.17 -20.50 -20.17 -19.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
98,408%
39.86
0.0405 38.81 38.66 38.55
Diluted Average Shares
98,408%
39.86
0.0405 38.81 38.66 38.55
Basic Earnings Per Share
12.28%
-0.50
-0.57 -0.53 -0.52 -0.51
Diluted Earnings Per Share
12.28%
-0.50
-0.57 -0.53 -0.52 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):